Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Treatment Intensity on Quality of Life in Patients With Metastatic Testicular Cancer.

Andrology·2026
Same author

Facilitators and barriers to medication adherence in systemic lupus erythematosus: a qualitative study in China.

Scientific reports·2026
Same author

Numerical study on the impacts of shunt pathway presence, anatomical characteristics, and occlusion degree in patients with spontaneous splenorenal shunt.

Computer methods in biomechanics and biomedical engineering·2026
Same author

Reducing descending aortic tortuosity improves thoracic endovascular aortic repair outcomes in type B aortic dissection: from a hemodynamic perspective.

Biomechanics and modeling in mechanobiology·2026
Same author

Clear Cell Renal Cell Carcinoma: Rare and Atypical Metastatic Localizations-A Case Series.

Case reports in urology·2026
Same author

Hemodynamic parameters as biomarkers for predicting microvascular decompression efficacy in classic trigeminal neuralgia.

Journal of neurosurgery·2026

Related Experiment Video

Updated: Jul 18, 2025

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

10.0K

[Neutropenia - when is GCSF support indicated?]

Marc Rehlinghaus1,2, Philipp Rehker1,2, Yue Che1,2

  • 1Department of Urology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Aktuelle Urologie
|August 22, 2023
PubMed
Summary

Systemic cancer treatments can cause neutropenia, increasing infection risk. Granulocyte colony-stimulating factors (G-CSF) help manage neutropenic fever and prevent infections in genitourinary oncology patients.

More Related Videos

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents
14:04

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents

Published on: March 25, 2016

15.3K
Neutrophil Lifespan Extension with CLON-G and an In Vitro Spontaneous Death Assay
05:52

Neutrophil Lifespan Extension with CLON-G and an In Vitro Spontaneous Death Assay

Published on: May 12, 2023

1.4K

Related Experiment Videos

Last Updated: Jul 18, 2025

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

10.0K
Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents
14:04

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents

Published on: March 25, 2016

15.3K
Neutrophil Lifespan Extension with CLON-G and an In Vitro Spontaneous Death Assay
05:52

Neutrophil Lifespan Extension with CLON-G and an In Vitro Spontaneous Death Assay

Published on: May 12, 2023

1.4K

Area of Science:

  • Genitourinary Oncology
  • Hematology
  • Pharmacology

Context:

  • Systemic treatments in genitourinary oncology often impair hematopoiesis, leading to neutropenia.
  • Neutropenia increases patient vulnerability to severe infections, with fever as a primary symptom.
  • Neutropenic fever poses a significant threat, potentially causing life-threatening complications and negatively impacting treatment outcomes.

Purpose:

  • To provide an updated, practice-oriented overview of Granulocyte Colony-Stimulating Factor (G-CSF) application in uro-oncology.
  • To align with current German and international guidelines for G-CSF use.
  • To clarify indications for G-CSF support based on therapy risk, patient factors, and treatment intent.

Summary:

  • Neutropenia, a common side effect of genitourinary cancer therapies, elevates infection risks.
  • Granulocyte colony-stimulating factors (G-CSF) are crucial for managing neutropenic fever and prophylaxis.
  • Optimal G-CSF use requires assessing therapy-related risks, patient-specific factors, and treatment goals (palliative vs. curative).

Impact:

  • Improved management of neutropenic fever in genitourinary cancer patients.
  • Reduced incidence of severe infections and therapy complications.
  • Enhanced patient quality of life and potentially improved treatment prognosis through appropriate G-CSF utilization.